Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Finasteride to prevent morbidity from benign prostatic hyperplasia

Article Abstract:

Finasteride can reduce the symptoms of prostatic hyperplasia and the need for prostate surgery, but it may not be the best choice for many men. In a study of men with large prostate glands and significant urinary difficulty, finasteride reduced the rates of surgery and acute inability to urinate by over 50%. For many men, however, other drugs or simple lifestyle changes can improve urinary symptoms, and surgical resection of the prostate can provide definitive treatment for men in whom it is indicated. Prescribing finasteride widely may not be the optimal approach to prostate enlargement.

Author: Wasson, John H.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Finasteride

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia

Article Abstract:

Finasteride does not appear to be effective in the treatment of enlarged prostate. Researchers evaluated the effectiveness of finasteride and terazosin in 1,229 men with enlarged prostate who were randomly assigned to take finasteride, terazosin, both drugs or a placebo. Terazosin and the combination of terazosin and finasteride significantly reduced symptoms but finasteride alone was no more effective than the placebo. Terazosin belongs to a class of drugs that relax the smooth muscle of the prostate while finasteride is a drug that lowers blood levels of male hormones.

Author: Barry, Michael J., Haakenson, Clair, Williford, William O., Dixon, Christopher M., Lepor, Herbert, Padley, Robert J., Brawer, Michael K., Gormley, Glenn, Machi, Madeline, Narayan, Perinchery
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Treatment of benign prostatic hyperplasia

Article Abstract:

Conflicting results from clinical trials of finasteride may occur because benign prostatic hyperplasia is two different disorders. A 1996 Veterans Affairs study comparing finasteride with terazosin found that finasteride was no more effective than placebo. However, the researchers did not limit the study to only those men who had enlarged prostates. Finasteride has been shown effective in other trials that limited the treatment to men with enlarged prostates. Men who do not have enlarged prostates may benefit more from terazosin.

Author: Walsh, Patrick C.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1996
Health aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Editorial, Evaluation, Prostate, Prostatic hyperplasia, Drug therapy, Enzyme inhibitors, Prostate diseases, Prostatic diseases, Terazosin hydrochloride, Terazosin
Similar abstracts:
  • Abstracts: Capital idea: AMA project an investment in the future of the profession. Medical staff section expands focus beyond hospitals
  • Abstracts: Panel at work on patient bill of rights. Quality data target providers, payers
  • Abstracts: An international study of the relation between somatic symptoms and depression. Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment: a randomized controlled trial
  • Abstracts: A randomized trial of open versus closed vaginal vault in the prevention of postoperative morbidity after abdominal hysterectomy
  • Abstracts: Immunological comparison of patients with rheumatoid arthritis with and without nephropathy. Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.